Terminated NCT00934635
This study was terminated in Germany. It is testing Positron-Emission-Tomography Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone for schizophrenia.
In Aachen Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 50 Years
Countries Germany
Sponsor Janssen-Cilag G.m.b.H
Condition Schizophrenia Completed NCT02164981
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Boston Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Schizophrenia Terminated NCT04975035
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 40 Years
Countries
Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine
Condition Schizophrenia Completed NCT02192723
This study is completed in China. It is testing Randomized Double-blind Trial With 6 Antipsychotic Drugs for schizophrenia.
In Beijing Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 25 Years to 60 Years
Countries China
Sponsor Beijing HuiLongGuan Hospital
Condition Schizophrenia Completed NCT00350467
This study is completed in China. It is testing Extended Release(ER) Paliperidone for schizophrenia.
Multiple locations, including Beijing Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries China
Sponsor Xian-Janssen Pharmaceutical Ltd.
Condition Schizophrenia Terminated NCT01615185
This study was terminated in Taiwan. It is testing Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride for schizophrenia.
In Kaohsiung City Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries Taiwan
Sponsor Kaohsiung Kai-Suan Psychiatric Hospital
Condition Schizophrenia Completed NCT03319953
This study is completed in the United Kingdom. It is testing Effects of TAK-041 on Motivational Anhedonia for schizophrenia.
In London Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United Kingdom
Sponsor Neurocrine Biosciences
Condition Schizophrenia Completed NCT00723606
This study is completed in China. It is testing intramuscular Ziprasidone for Schizophrenia.
Multiple locations, including Baoding Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries China
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia Completed NCT04655287
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 65 Years
Countries
Sponsor University Hospital, Akershus
Condition Schizophrenia, Bipolarity Completed NCT00283517
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Janssen-Cilag, S.A.
Condition Schizophrenia Terminated NCT00929370
This study was terminated in the United States. It focuses on schizophrenia.
Multiple locations, including Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor GlaxoSmithKline
Condition Schizophrenia Completed NCT01212575
This study is completed in Denmark. It focuses on schizophrenia.
Multiple locations, including Aabenraa Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational From 18 Years to 65 Years
Countries Denmark
Sponsor AstraZeneca
Condition Schizophrenia 
